Esperion Therapeutics
ESPR
#6663
Rank
C$1.16 B
Marketcap
C$4.53
Share price
0.00%
Change (1 day)
33.22%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$1.09 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are C$1.09 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$1.05 B0.03%
2024-12-31C$1.05 B19.94%
2023-12-31C$0.87 B12.97%
2022-12-31C$0.77 B5.22%
2021-12-31C$0.73 B28.67%
2020-12-31C$0.57 B125.57%
2019-12-31C$0.25 B189.87%
2018-12-31C$87.63 M110.3%
2017-12-31C$41.67 M86.67%
2016-12-31C$22.32 M93.58%
2015-12-31C$11.53 M2.21%
2014-12-31C$11.28 M152.17%
2013-12-31C$4.47 M-81.79%
2012-12-31C$24.56 M193.19%
2011-12-31C$8.37 M
2002-12-31C$20 M6.03%
2001-12-31C$18.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$164.83 B 14,909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$14.28 B 1,200.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$2.20 B 100.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C$0.10 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.96 B-12.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$7.69 B 601.11%๐Ÿ‡บ๐Ÿ‡ธ USA